The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| FLGT | +70.59% | -32.56% | -7.58% | +217% |
| S&P | +12.26% | +86.71% | +13.3% | +209% |
Fulgent Genetics is a technology company that provides comprehensive diagnostic genetic testing using its proprietary platform, which integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools, and integrated laboratory processes.
Fulgent Genetics has seen its fortunes shift since the pandemic. Is it a solid investment or a risky bet? Join us as we break down its performance and management decisions.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $84.07M | 17.2% |
| Gross Profit | $33.49M | 35.1% |
| Gross Margin | 39.83% | 5.3% |
| Market Cap | $691.76M | 5.1% |
| Market Cap / Employee | $0.53M | 0.0% |
| Employees | 1.3K | 10.9% |
| Net Income | -$6.83M | 53.5% |
| EBITDA | -$9.31M | 16.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $117.64M | 102.7% |
| Accounts Receivable | $71.19M | 24.2% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $5.67M | -25.4% |
| Short Term Debt | $2.32M | -0.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -3.51% | 9.2% |
| Return On Invested Capital | 14.89% | -0.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $5.06M | 114.4% |
| Operating Free Cash Flow | $11.11M | 171.6% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.50 | 0.46 | 0.54 | 0.62 | 6.28% |
| Price to Sales | 2.00 | 1.78 | 2.00 | 2.20 | -7.45% |
| Price to Tangible Book Value | 0.58 | 0.53 | 0.63 | 0.72 | 5.96% |
| Price to Free Cash Flow TTM | 179.46 | 35.99 | 50.49 | - | |
| Enterprise Value to EBITDA | -31.50 | -14.75 | -23.23 | -34.58 | -15.06% |
| Free Cash Flow Yield | 0.6% | 2.8% | 2.0% | - | |
| Return on Equity | -3.8% | -3.6% | -4.5% | -3.8% | -72.42% |
| Total Debt | $9.23M | $8.28M | $7.92M | $7.99M | -19.65% |
No podcast episodes available.
FLGT earnings call for the period ending June 30, 2022.
FLGT earnings call for the period ending March 31, 2022.
FLGT earnings call for the period ending December 31, 2021.
FLGT earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
